Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The Dual Function of KDM5C in Both Gene Transcriptional Activation and Repression Promotes Breast Cancer Cell Growth and Tumorigenesis
Advanced Science ( IF 14.3 ) Pub Date : 2021-02-18 , DOI: 10.1002/advs.202004635 Hai-Feng Shen 1 , Wen-Juan Zhang 1 , Ying Huang 1 , Yao-Hui He 1 , Guo-Sheng Hu 1 , Lei Wang 1 , Bing-Ling Peng 1 , Jia Yi 1 , Ting-Ting Li 2 , Rui Rong 2 , Xiao-Yan Chen 3 , Jun-Yi Liu 2 , Wen-Juan Li 1 , Kenny Ohgi 4 , Shao-Wei Li 2 , Michael G Rosenfeld 4 , Wen Liu 1
Advanced Science ( IF 14.3 ) Pub Date : 2021-02-18 , DOI: 10.1002/advs.202004635 Hai-Feng Shen 1 , Wen-Juan Zhang 1 , Ying Huang 1 , Yao-Hui He 1 , Guo-Sheng Hu 1 , Lei Wang 1 , Bing-Ling Peng 1 , Jia Yi 1 , Ting-Ting Li 2 , Rui Rong 2 , Xiao-Yan Chen 3 , Jun-Yi Liu 2 , Wen-Juan Li 1 , Kenny Ohgi 4 , Shao-Wei Li 2 , Michael G Rosenfeld 4 , Wen Liu 1
Affiliation
|
Emerging evidence suggested that epigenetic regulators can exhibit both activator and repressor activities in gene transcriptional regulation and disease development, such as cancer. However, how these dual activities are regulated and coordinated in specific cellular contexts remains elusive. Here, it is reported that KDM5C, a repressive histone demethylase, unexpectedly activates estrogen receptor alpha (ERα)‐target genes, and meanwhile suppresses type I interferons (IFNs) and IFN‐stimulated genes (ISGs) to promote ERα‐positive breast cancer cell growth and tumorigenesis. KDM5C‐interacting protein, ZMYND8, is found to be involved in both processes. Mechanistically, KDM5C binds to active enhancers and recruits the P‐TEFb complex to activate ERα‐target genes, while inhibits TBK1 phosphorylation in the cytosol to repress type I IFNs and ISGs. Pharmacological inhibition of both ERα and KDM5C is effective in inhibiting cell growth and tumorigenesis. Taken together, it is revealed that the dual activator and repressor nature of an epigenetic regulator together contributes to cancer development.
中文翻译：
KDM5C 在基因转录激活和抑制中的双重功能促进乳腺癌细胞生长和肿瘤发生
新的证据表明，表观遗传调节因子可以在基因转录调节和疾病发展（例如癌症）中表现出激活剂和抑制剂活性。然而，如何在特定的细胞环境中调节和协调这些双重活动仍然难以捉摸。据报道，KDM5C（一种抑制性组蛋白去甲基化酶）意外地激活雌激素受体 α (ER α ) 靶基因，同时抑制 I 型干扰素 (IFN) 和 IFN 刺激基因 (ISG)，从而促进 ER α阳性乳腺癌癌细胞生长和肿瘤发生。研究发现 KDM5C 相互作用蛋白 ZMYND8 参与这两个过程。从机制上讲，KDM5C 与活性增强子结合并招募 P-TEFb 复合物来激活 ER α靶基因，同时抑制胞浆中的 TBK1 磷酸化以抑制 I 型 IFN 和 ISG。 ERα和KDM5C的药理学抑制可有效抑制细胞生长和肿瘤发生。综上所述，表观遗传调节剂的双重激活剂和阻遏物性质共同促进了癌症的发展。
更新日期：2021-02-18
中文翻译：
KDM5C 在基因转录激活和抑制中的双重功能促进乳腺癌细胞生长和肿瘤发生
新的证据表明，表观遗传调节因子可以在基因转录调节和疾病发展（例如癌症）中表现出激活剂和抑制剂活性。然而，如何在特定的细胞环境中调节和协调这些双重活动仍然难以捉摸。据报道，KDM5C（一种抑制性组蛋白去甲基化酶）意外地激活雌激素受体 α (ER α ) 靶基因，同时抑制 I 型干扰素 (IFN) 和 IFN 刺激基因 (ISG)，从而促进 ER α阳性乳腺癌癌细胞生长和肿瘤发生。研究发现 KDM5C 相互作用蛋白 ZMYND8 参与这两个过程。从机制上讲，KDM5C 与活性增强子结合并招募 P-TEFb 复合物来激活 ER α靶基因，同时抑制胞浆中的 TBK1 磷酸化以抑制 I 型 IFN 和 ISG。 ERα和KDM5C的药理学抑制可有效抑制细胞生长和肿瘤发生。综上所述，表观遗传调节剂的双重激活剂和阻遏物性质共同促进了癌症的发展。
京公网安备 11010802027423号